This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Identify bond funds that offer tax-exempt income in retirement and how to incorporate them for tax-efficient withdrawals.
23,934 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
If you’re weighing Peloton as an investment, you’re not alone. This piece lays out two essential reasons I haven’t bo...
SoFi faced a high-profile attack from a famed short-seller, sending shares lower. This deep dive explains what the re...
Oil trading desks warn that disruptions through the Strait of Hormuz could trigger a global crude supply squeeze as A...
The YieldMax PYPL Option Income Strategy ETF is under pressure as its strategy to harvest option premiums collides wi...
Oil prices surged on geopolitical risk as US-Iran tensions flared, while crypto markets paused ahead of a major presa...
When crises hit, your money should follow a simple playbook: protect essentials, cut waste, and plan for recovery. Th...
XRP trades near $1.45 as policy and liquidity headlines drive the 12-month outlook. Analysts map three potential path...
Cantor8 announces a major expansion into Africa's mobile money scene, linking M-PESA and EVC Plus to its Canton Netwo...
A small lithium technology firm surged to a $1B valuation after unveiling a breakthrough recovery method, signaling a...
After a strong rally, investors ask if AMD remains a smart bet. This in-depth look weighs AI roadmaps, growth drivers...
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...